ARS Pharmaceuticals, Inc. Common Stock SPRY
$3.89
+2.10%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-11-05 | View → |
| 8-K | 8-K | 2026-11-05 | View → |
| 4 | Insider transaction | 2026-11-04 | View → |
| 4 | Insider transaction | 2026-10-05 | View → |
| 4 | Insider transaction | 2026-09-02 | View → |
| 10-Q | 10-Q | 2026-08-13 | View → |
| 8-K | 8-K | 2026-08-13 | View → |
| 8-K | 8-K | 2026-07-17 | View → |
| 8-K | 8-K | 2026-07-07 | View → |
| 4 | Insider transaction | 2026-07-02 | View → |
| 4 | Insider transaction | 2026-06-26 | View → |
| 4 | 4 | 2026-06-26 | View → |
| 4 | Insider transaction | 2026-06-26 | View → |
| 4 | Insider transaction | 2026-06-26 | View → |
| 4 | Insider transaction | 2026-06-26 | View → |
| 4 | Insider transaction | 2026-06-26 | View → |
| 4 | Insider transaction | 2026-06-26 | View → |
| 4 | Insider transaction | 2026-06-26 | View → |
| 4 | Insider transaction | 2026-06-26 | View → |
| 8-K | 8-K | 2026-06-25 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 10-Q | 10-Q | 2026-05-15 | View → |
| 8-K | 8-K | 2026-05-15 | View → |
| 8-K | 8-K | 2026-05-13 | View → |
| DEF 14A | DEF 14A | 2026-04-29 | View → |
| 10-K | 10-K | 2026-03-09 | View → |
| 8-K | 8-K | 2026-03-09 | View → |
| 4 | Insider transaction | 2026-01-05 | View → |
| 4 | Insider transaction | 2026-01-05 | View → |
| 4 | Insider transaction | 2026-01-05 | View → |
| 4 | Insider transaction | 2026-01-05 | View → |
| 4 | Insider transaction | 2026-01-05 | View → |
| 4 | Insider transaction | 2026-01-05 | View → |
| 4 | Insider transaction | 2026-01-05 | View → |
| 4 | Insider transaction | 2025-11-14 | View → |
| 4 | Insider transaction | 2025-11-14 | View → |
| 4 | Insider transaction | 2025-11-14 | View → |
| 10-Q | 10-Q | 2025-11-10 | View → |
| 8-K | 8-K | 2025-11-10 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $3.89
- Market Cap
- $383.01 million
- 52-Week Range
- $2.44 – $13.15
- Average Volume
- 2.06 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.